2 Pradaxa Doses Beat Warfarin in Afib (CME/CE)

(MedPage Today) -- Considering both efficacy and safety, both the 110-mg and 150-mg doses of dabigatran (Pradaxa) had a net clinical benefit compared with warfarin in patients with atrial fibrillation, researchers found.
Source: MedPage Today State Required CME - Category: Consumer Health News Source Type: news